Cagrilintide monotherapy uses up to 4.5 mg weekly, while retatrutide reaches 12 mg weekly, but combining these maximum doses would almost certainly be unsafe
Please call us at 901.701.7010 or stop by the front desk and well be happy to help
This often can coincide with high circulating insulin and insulin sensitivity which affects the rate at which skin cells proliferate and form throughout the strata of the epidermis
As an investigational triple-agonist, every Retatrutide protocol is reserved for carefully selected adults across Newport Beach, Costa Mesa, Irvine, Laguna Beach, and Orange County who need deeper metabolic intervention than Semaglutide or Tirzepatide can provide
Community observations should inform but not replace careful individual risk assessment
Quick Overview: Research strongly advises against using GLP-1 medications during pregnancy